| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/20/2007 | WO2007106435A2 Cleavable vaccines compositions and methods of making and using the same |
| 09/20/2007 | WO2007106415A2 Triggered self-assembly conjugates and nanosystems |
| 09/20/2007 | WO2007106120A2 Serum albumin binding peptides for tumor targeting |
| 09/20/2007 | WO2007106073A2 Modified pathogens for use as vaccines |
| 09/20/2007 | WO2007106071A2 Method for switching magnetic random access memory elements and magnetic element structures |
| 09/20/2007 | WO2007105981A1 Solid oral form of a medicinal preparation and a method for the production thereof |
| 09/20/2007 | WO2007105169A2 Vaccine against streptococcus agalactiae infection using native or recombinant s. agalactiae glyceraldheyde-3-phosphate dehydrogenase (gapdh) as a target antigen |
| 09/20/2007 | WO2007105024A1 Pharmaceutical compositions comprising sods and prolamine based peptide fragments |
| 09/20/2007 | WO2007104999A1 Anti-cancer therapy |
| 09/20/2007 | WO2007104979A1 Virus-like particles of rift valley fever virus |
| 09/20/2007 | WO2007104581A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans |
| 09/20/2007 | WO2007104562A1 Dry powder compositions and systems for poultry vaccination |
| 09/20/2007 | WO2007104529A2 Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 09/20/2007 | WO2007104523A1 Use of iex-1 for the treatment of glioma tumors |
| 09/20/2007 | WO2007104511A1 Cancer vaccine |
| 09/20/2007 | WO2007104451A1 Live attenuated bordetella strains as a single dose vaccine against whooping cough |
| 09/20/2007 | WO2007104263A1 An enhancin of hepatitis b virus vaccine and its gene |
| 09/20/2007 | WO2007082715A3 Anti-cd19 antibody composition and method |
| 09/20/2007 | WO2007079457A3 Materials and methods for immunizing against fiv infection |
| 09/20/2007 | WO2007070996A3 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis |
| 09/20/2007 | WO2007063311A3 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007063308A3 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007058823A3 Anti-egfr antibodies |
| 09/20/2007 | WO2007056114B1 Compositions and methods for the detection of trypanosoma cruzi infection |
| 09/20/2007 | WO2007048122A3 Antibody-based therapeutics with enhanced adcc activity |
| 09/20/2007 | WO2007035842A3 Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac) |
| 09/20/2007 | WO2007016185A3 Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination |
| 09/20/2007 | WO2006048174A8 Immunoglobulin fractions |
| 09/20/2007 | WO2005027871A3 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 09/20/2007 | WO2005011590A3 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 09/20/2007 | WO2004069176A3 Polymer conjugates of mutated neublastin |
| 09/20/2007 | US20070219347 Meningitidis B serogroup; amino acid sequence encoded by nucleotides 564043 to 565882 of sequence 1; monoclonal antibodies; vaccine antigens |
| 09/20/2007 | US20070219264 inhibiting rejection of a transplanted organ, tissue or cell in a recipient mammal; immunosuppressive agent; autoimmune diseases |
| 09/20/2007 | US20070219149 Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity |
| 09/20/2007 | US20070218536 Polyvalent Viral Vectors and a System for Production Thereof |
| 09/20/2007 | US20070218086 Adjuvant Composition and Methods for Its Use |
| 09/20/2007 | US20070218085 Botulinum toxin therapy for neuropsychiatric disorders |
| 09/20/2007 | US20070218084 Method for the Mapping of the Epileptogenic Focus in the Pre-Surgical Evaluation of Patients with Intractable Epilepsy |
| 09/20/2007 | US20070218083 Methods for facilitating weight loss |
| 09/20/2007 | US20070218082 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 09/20/2007 | US20070218081 Adipogenic adenoviruses as a biomarker for disease |
| 09/20/2007 | US20070218080 Peptide antigen of human papillomavirus type 16 and application thereof |
| 09/20/2007 | US20070218079 Method to induce rnai in prokaryotic organisms |
| 09/20/2007 | US20070218078 Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218075 immunogens; glutamine based point mutations |
| 09/20/2007 | US20070218074 Vaccine mixture comprising e6/e7 human papilloma viral amino acid sequences for use as therapeutic targeting tools in treatment of uterine cancer |
| 09/20/2007 | US20070218073 Antigenic composition |
| 09/20/2007 | US20070218072 Methods of improving health-related quality of life in individuals with systemic lupus erythematosus |
| 09/20/2007 | US20070218071 Novel therapeutic targets in cancer |
| 09/20/2007 | US20070218070 Methods of modulation of the immune system |
| 09/20/2007 | US20070218069 antibodies that specifically binds ubiquitin comprising a lysine linkage between a lysine residue of one ubiquitin molecule and the C-terminal glycine residue of another ubiquitin molecule |
| 09/20/2007 | US20070218068 Human Autism Predisposition Gene Encoding a Transcription Factor and Uses Thereof |
| 09/20/2007 | US20070218067 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors |
| 09/20/2007 | US20070218066 For clinical screening, diagnosis, prognosis, therapy and prophylaxis of conditions involving the pathology of epithelial cells and particularly those of the alimentary canal |
| 09/20/2007 | US20070218065 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 09/20/2007 | US20070218064 Human anti-il-23 antibodies, compositions, methods and uses |
| 09/20/2007 | US20070218063 Method and composition for treatment of renal disease with antibodies and their equivalents |
| 09/20/2007 | US20070218062 Methods of treating lupus using CD4 antibodies |
| 09/20/2007 | US20070218061 Use of ephrinb2 directed agents for the treatment or prevention of viral infections |
| 09/20/2007 | US20070218059 Cell Surface Marker |
| 09/20/2007 | US20070218058 Methods For Inducing Autolysis In Infectious Bacteria |
| 09/20/2007 | US20070218057 Human Obesity Susceptibility Gene and Uses Thereof |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218055 Ferroportin1 nucleic acids and proteins |
| 09/20/2007 | US20070218054 In Vitro germinal centers |
| 09/20/2007 | US20070218053 Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease |
| 09/20/2007 | US20070218052 Novel lgG3 Antibodies for Stimulating Phagocytosis |
| 09/20/2007 | US20070218051 Epitope peptides immunogenic against Streptococcus pneumoniae |
| 09/20/2007 | US20070218050 Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear |
| 09/20/2007 | US20070218049 Nanoparticle based photodynamic therapy and methods of making and using same |
| 09/20/2007 | US20070218048 Sfec, a Sperm Flagellar Energy Carrier Protein |
| 09/20/2007 | US20070218037 Therapeutic agent for fibromyalgia |
| 09/20/2007 | US20070218032 B7-h4 expression on tumor vasculature |
| 09/20/2007 | US20070218008 Methods of screening agents, conjugates or conjugate moieties for the ability to enter the CNS by crossing the blood brain barrier in order to treat or diagnose conditions within the CNS; methods entail providing a cell expressing SVCT2 transporter, transporter being situated in plasma membrane of cell |
| 09/20/2007 | US20070218000 component of outer membrane preparations of Neisseria meningitidis capable of inducing bactericidal activity; formulations with the ability to increase the protective spectrum of existing vaccines and hence expanding it against different pathogens |
| 09/20/2007 | US20070217997 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors |
| 09/20/2007 | CA2645810A1 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement |
| 09/20/2007 | CA2645674A1 Pharmaceutical compositions comprising sods and prolamine based peptide fragments |
| 09/20/2007 | CA2645617A1 Compositions and methods for immunisation using cd1d ligands |
| 09/20/2007 | CA2645507A1 Vaccine for viruses that cause persistent or latent infections |
| 09/20/2007 | CA2645475A1 Solid oral form of a medicinal preparation and a method for the production thereof |
| 09/20/2007 | CA2645190A1 Live attenuated bordetella strains as a single dose vaccine against whooping cough |
| 09/20/2007 | CA2645097A1 Anti-5t4 antibodies and uses thereof |
| 09/20/2007 | CA2644694A1 Triggered self-assembly conjugates and nanosystems |
| 09/20/2007 | CA2644405A1 Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 09/20/2007 | CA2643737A1 Cancer vaccine |
| 09/20/2007 | CA2642869A1 Method of detecting or diagnosing of a neurodegenerative disease or condition |
| 09/19/2007 | EP1835031A1 Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans |
| 09/19/2007 | EP1835029A1 Papillomavirus vaccines |
| 09/19/2007 | EP1835027A1 Novel cancer antigen peptide and the use thereof |
| 09/19/2007 | EP1834671A2 A method for generation of antibodies to cell surface molecules |
| 09/19/2007 | EP1834651A1 Compositions and methods for veterinary vaccination |
| 09/19/2007 | EP1834650A1 Cancer vaccine preparation |
| 09/19/2007 | EP1834649A1 Method of developing a process for producing an allergen extract |
| 09/19/2007 | EP1834648A1 Process for producing an allergen extract |
| 09/19/2007 | EP1833992A2 Pcv2 immunogenic compositions and methods of producing such compositions |
| 09/19/2007 | EP1833991A2 Trefoil factors and methods of treating proliferation disorders using same |
| 09/19/2007 | EP1833989A1 Virus preparations and methods |
| 09/19/2007 | EP1833968A1 Cancer specific antibody and cell surface proteins |